2:24:06 AM PDT - Friday, September 30th, 2022

Private Equity Sees the Billions in Eye Care as Firms Target High-Profit Procedures  

By Editor - Mon Sep 19, 3:21 am

ST. LOUIS — Christina Green hoped cataract surgery would clear up her cloudy vision, which had worsened after she took a drug to fight her breast cancer. But the former English professor said her 2019 surgery with Ophthalmology Consultants didn’t get her to 20/20 vision or fix her astigmatism — despite a $3,000 out-of-pocket charge for the astigmatism surgical upgrade. Green, 69, said she ended up feeling more like a dollar sign to the practice than a patient. “You’re a cow among a herd as you just move from this station to this station to this station,” she said

See the rest here:

Private Equity Sees the Billions in Eye Care as Firms Target High-Profit Procedures

Leave a Reply

You must sign in to post a comment.